Acquisition
-
Lilly to Acquire Verve Therapeutics to Develop One-Time Cardiovascular Therapies for High-Risk Patients
Eli Lilly will acquire Verve Therapeutics, a clinical-stage company focused on gene editing therapies for cardiovascular disease. The deal, valued at approximately $1 billion, aims to advance Verve’s one-time treatment approach targeting genes linked to heart disease. Lilly plans to leverage its expertise in cardiometabolic diseases and gene medicines to develop Verve’s pipeline, including VERVE-102.
-
VSA to Acquire HopeAI, Expanding into AI in Life Science
TCTM Kids IT Education Inc. (VSA) announced a non-binding LOI to acquire HopeAI, a leader in AI solutions for clinical development. This move aims to expand VSA’s presence in the AI-driven biopharmaceutical sector. HopeAI’s platforms offer solutions to reduce clinical trial timelines and improve efficiency. The acquisition is subject to customary closing conditions and will allow VSA to leverage HopeAI’s technology to advance drug development.
-
BEST SPAC I Acquisition Corp. Announces Closing of $55 Million IPO
BEST SPAC I Acquisition Corp. completed its $55 million IPO, priced at $10 per unit, on Nasdaq under the symbol BSAAU. The British Virgin Islands-based SPAC’s offering, managed by Maxim Group LLC, includes an over-allotment option. With focus on the consumer goods sector, the company aims to merge with a suitable target. The SEC declared the registration statement effective on June 12, 2025.
-
TotalEnergies Deepens U.S. Offshore Footprint: Expands Partnership with Chevron in 40 Exploration Blocks
TotalEnergies acquired a 25% stake in 40 offshore exploration leases from Chevron in the U.S., spanning ~1,000 sq km across Walker Ridge, Mississippi Canyon, and East Breaks areas. This expands TotalEnergies’ U.S. offshore presence, building on collaborations with Chevron in projects like Ballymore and Anchor. The move reinforces TotalEnergies’ commitment to low-emission projects and its integrated energy strategy, including significant investments in LNG and renewables in the U.S. since 2022.
-
IQSTEL’s GlobeTopper Acquisition Fuels Rapid Global Fintech Expansion, Accelerating $1 Billion Growth Plan
IQSTEL Inc. announced an agreement to acquire a 51% stake in fintech innovator GlobeTopper, aiming to expand its global footprint and reach a $1 billion revenue goal by 2027. The acquisition, valued up to $700,000, will leverage GlobeTopper’s projected $65 million in 2025 revenue and existing client base across the Americas, Europe, and Africa, integrating its operations in the IQSTEL’s Fintech Division.